25 May 2013
Keywords: Eli Lilly, Biotech capabilitie, Multi-specific drugs, Investment
Article | 29 June 2011
US drug major Eli Lilly (NYSE: LLY) yesterday revealed plans for a multi-million dollar investment to expand its existing biotechnology ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 June 2011
24 May 2013
© 2013 thepharmaletter.com